Is the Lao version of Venetocla/Venetocla genuine?

Venetoclax/Venetoclax (Venetoclax) is a targeted anti-cancer drug mainly used to treat certain types of blood cancers, especially chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Veneclat exerts its anti-tumor effects by inhibiting the function of the B-cell lymphoma 2 (BCL-2) protein. BCL-2 is an anti-apoptotic protein that is overexpressed in many cancer cells and can help cancer cells resist normal programmed death, leading to continued tumor growth. The mechanism of venetoclax is to promote the apoptosis of cancer cells by selectively binding to BCL-2, thereby effectively reducing the number of cancer cells.

During treatment, venetoclax is often combined with other chemotherapy drugs or targeted therapies to enhance its efficacy. A patient's specific treatment plan is often individualized based on the type and stage of the cancer, as well as previous treatment history. While using venetoclax, your doctor will regularly monitor your patient's health to evaluate the drug's effectiveness and side effects.

Regarding the legality and authenticity of the Lao version of Venetekla, the Lao version of Veneteklat is a generic drug, and its original drug is developed and produced by AbbVie Inc. and Genentech, a subsidiary of the Swiss Roche Group. Generic drugs are usually manufactured by other pharmaceutical companies after the patent of the original drug expires. The purpose is to reduce the cost of the drug and allow more patients to obtain the treatment they need. The price of each box of 100mg*120 tablets is more than 2,000 yuan. Although generic drugs are similar to the original drugs in terms of ingredients and effects, when purchasing the Lao version of Venacla, you need to carefully check the outer packaging, labels and instructions of the drug to confirm its manufacturer, approval number and other information.

Reference materials:https://www.drugs.com/venetoclax.html